Cooper CS, Eeles R, Wedge D, …, Clark J, …, Brewer D, … et al. The Life History of Multifocal Prostate Cancer: Multiple Independent Clonal Expansions in Neoplastic and Normal Prostate Tissue. [under review]
Merson S, Yang ZH, Brewer D, Olmos D, Eichholz A, McCarthy F, G, Fisher, Kovacs G, Berney DM, Foster CS, Møller H, Scardino P, Cuzick J, Cooper CS, Clark JP on behalf of the Transatlantic prostate cancer Group. Focal amplification of the androgen receptor gene in hormone-naïve human prostate cancer. [under review]
Olmos D, Brewer D, Clark J, …, Cooper CS et al. Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study. The Lancet Oncology. 2012, 13: 1114-24
Santarius T, Shipley J, Brewer D, Stratton MR, and Cooper CS. A census of amplified and overexpressed human cancer genes. Nature Reviews. Cancer, 2010, 10: 59-64
Reid AH, Attard G, …, Cooper CS. Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer. Mod Pathol. 2012, 25: 902-10
Kote-Jarai Z, Olama AA, …, Cooper CS, …, Easton DF, Eeles RA. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet. 2011, 43: 785-91
McCarthy F, Dennis N, Flohr P, Jhavar S, Parker C, Cooper CS. High-density tissue microarrays from prostate needle biopsies. J Clin Pathol. 2011, 64: 88-9
Attard G, de Bono JS, Clark J, Cooper CS. Studies of TMPRSS2-ERG gene fusions in diagnostic trans-rectal prostate biopsies. Clin Cancer Res. 2010, 16: 1340
Reid AH, Attard G, …, Cooper CS; Transatlantic Prostate Group. Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer. 2010, 102: 678-84.
Attard G, Cooper CS, de Bono JS. Steroid hormone receptors in prostate cancer: a hard habit to break? Cancer Cell. 2009 Dec 8;16(6):458-62.